Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Narcolepsy Type 1

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

January 1, 2024

Conditions
Narcolepsy Type 1Fmri
Interventions
DEVICE

transcutaneous auricular vagus nerve stimulation

Transcutaneous auricular vagus nerve stimulation (tVNS) is a newly developed treatment for neuromodulation. It offers advantages such as being non-invasive, cost-effective, and not requiring battery changes, unlike invasive vagus nerve stimulation (iVNS). The auricular branch of the vagus nerve, which is the only afferent branch distributed on the surface of the human body, can be directly stimulated to produce effects similar to classic vagus nerve stimulation (VNS)

Trial Locations (1)

710000

Liu Yonghong, Xi'an

All Listed Sponsors
lead

Liu Yonghong

OTHER